By contrast, copy numbers of RB1 or TP53 were not associated with AGR2 expression, showing that the relationship between AGR2 expression and oncogenic features in breast cancer is certainly complex and requires more in-depth analysis. This evidence concerns the gene TP53 and breast cancer.